213 related articles for article (PubMed ID: 25633200)
41. Management of infantile hemangiomas : current and potential pharmacotherapeutic approaches.
Craiglow BG; Antaya RJ
Paediatr Drugs; 2013 Apr; 15(2):133-8. PubMed ID: 23456550
[TBL] [Abstract][Full Text] [Related]
42. Successful treatment of cutaneous hemangioma of infancy with topical imiquimod 5%: a report of 3 cases.
Senchak AJ; Dann M; Cable B; Bessinger G
Ear Nose Throat J; 2010 Mar; 89(3):E21-5. PubMed ID: 20229466
[TBL] [Abstract][Full Text] [Related]
43. Infantile hemangioma. Part 2: Management.
Sebaratnam DF; Rodríguez Bandera AL; Wong LF; Wargon O
J Am Acad Dermatol; 2021 Dec; 85(6):1395-1404. PubMed ID: 34419523
[TBL] [Abstract][Full Text] [Related]
44. Topical propranolol for treatment of superficial infantile hemangiomas.
Xu G; Lv R; Zhao Z; Huo R
J Am Acad Dermatol; 2012 Dec; 67(6):1210-3. PubMed ID: 22516113
[TBL] [Abstract][Full Text] [Related]
45. Topical timolol for periocular hemangioma: report of further study.
Ni N; Langer P; Wagner R; Guo S
Arch Ophthalmol; 2011 Mar; 129(3):377-9. PubMed ID: 21403002
[No Abstract] [Full Text] [Related]
46. Treatment of infantile hemangiomas with short-term application of imiquimod 5% cream.
Welsh O; Olazarán Z; Gómez M; Salas J; Berman B
J Am Acad Dermatol; 2004 Oct; 51(4):639-42. PubMed ID: 15389206
[TBL] [Abstract][Full Text] [Related]
47. Ulcerated infantile hemangioma treated with imiquimod.
Mascarenhas R; Guiote V; Agro J; Henrique M
Dermatol Online J; 2011 Sep; 17(9):13. PubMed ID: 21971278
[TBL] [Abstract][Full Text] [Related]
48. Imiquimod in the treatment of extensive recurrent lentigo maligna.
Kamin A; Eigentler TK; Radny P; Bauer J; Weide B; Garbe C
J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):51-2. PubMed ID: 15692515
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of the efficacy and safety of propranolol, timolol maleate, and the combination of the two, in the treatment of superficial infantile haemangiomas.
Gong H; Xu DP; Li YX; Cheng C; Li G; Wang XK
Br J Oral Maxillofac Surg; 2015 Nov; 53(9):836-40. PubMed ID: 26427968
[TBL] [Abstract][Full Text] [Related]
50. Topical timolol 0.5% gel-forming solution for small deep facial infantile hemangiomas.
Sorrell J; Chamlin SL
Pediatr Dermatol; 2013; 30(5):592-4. PubMed ID: 23889228
[TBL] [Abstract][Full Text] [Related]
51. Infantile hemangioma: treatment with short course systemic corticosteroid therapy as an alternative for propranolol.
Nieuwenhuis K; de Laat PC; Janmohamed SR; Madern GC; Oranje AP
Pediatr Dermatol; 2013; 30(1):64-70. PubMed ID: 22958179
[TBL] [Abstract][Full Text] [Related]
52. Topical Timolol Combined Intralesional Injection of Diprospan in the Treatment of Elevated Localized Mixed Infantile Hemangiomas and a Discussion for Proper Timing for Injection.
Zhang JY; Lan SJ; Liu M; Yang TY; Liu SS; Rong L
J Craniofac Surg; 2021 May; 32(3):988-990. PubMed ID: 33538448
[TBL] [Abstract][Full Text] [Related]
53. A prospective self-controlled study of topical timolol 0.5% cream for large superficial infantile hemangiomas.
Qiu Y; Yang J; Chen M; Chang L; Wang T; Ma G; Jin Y; Chen H; Lin X
J Dermatol; 2015 Apr; 42(4):363-6. PubMed ID: 25656976
[TBL] [Abstract][Full Text] [Related]
54. Fractional 2940-nm Er:YAG laser-assisted drug delivery of timolol maleate for the treatment of deep infantile hemangioma.
Sun L; Wang C; Cao Y; Lv X; Tian L; Liu D; Li L; Zhao W
J Dermatolog Treat; 2021 Dec; 32(8):1053-1059. PubMed ID: 32043380
[TBL] [Abstract][Full Text] [Related]
55. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe.
Schulze HJ; Cribier B; Requena L; Reifenberger J; Ferrándiz C; Garcia Diez A; Tebbs V; McRae S
Br J Dermatol; 2005 May; 152(5):939-47. PubMed ID: 15888150
[TBL] [Abstract][Full Text] [Related]
56. How to use bleomycin A5 for infantile maxillofacial haemangiomas: clinical evaluation of 82 consecutive cases.
Luo Q; Zhao F
J Craniomaxillofac Surg; 2011 Oct; 39(7):482-6. PubMed ID: 20675147
[TBL] [Abstract][Full Text] [Related]
57. Hemangiomas and the eye.
Spence-Shishido AA; Good WV; Baselga E; Frieden IJ
Clin Dermatol; 2015; 33(2):170-82. PubMed ID: 25704937
[TBL] [Abstract][Full Text] [Related]
58. Infantile hemangioma: clinical resolution with 5% imiquimod cream.
Martinez MI; Sanchez-Carpintero I; North PE; Mihm MC
Arch Dermatol; 2002 Jul; 138(7):881-4; discussion 884. PubMed ID: 12071813
[No Abstract] [Full Text] [Related]
59. Topical timolol for small hemangiomas of infancy.
Moehrle M; Léauté-Labrèze C; Schmidt V; Röcken M; Poets CF; Goelz R
Pediatr Dermatol; 2013; 30(2):245-9. PubMed ID: 22471694
[TBL] [Abstract][Full Text] [Related]
60. Brimonidine Toxicity Secondary to Topical Use for an Ulcerated Hemangioma.
Gill K; Bayart C; Desai R; Golden A; Raimer P; Tamburro J
Pediatr Dermatol; 2016 Jul; 33(4):e232-4. PubMed ID: 27282306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
